Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189349 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von S Anish Ruban und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bioprospecting Laboratory, Department of Botany, Bharathiar University, Coimbatore 641046, Tamil Nadu, India. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily G, Member 2, Drug Resistance, Neoplasm, Phytochemicals, Neoplasm Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Bharathiar University, University Grants Commission Department of Atomic Energy Consortium for Scientific Research, University Grants Commission.
Abstract (Originalsprache)
Drug resistance (DR) remains a significant challenge in cancer treatment, accounting for over 90 % of cancer-related deaths. Multidrug resistance (MDR) complicates chemotherapy by enabling cancer cells to evade therapeutic agents. This review focuses on the role of ATP-binding cassette (ABC) transporters, particularly the breast cancer resistance protein (BCRP), in mediating drug resistance. BCRP functions as a drug efflux pump, actively transporting chemotherapeutic agents out of cancer cells, thereby reducing their efficacy. The regulation of BCRP is influenced by various signaling pathways, including PI3K/AKT, MAPK/ERK, NF-κB, and Wnt/β-catenin, all of which collectively enhance its expression and contribute to the MDR phenotype. Recent studies have highlighted the potential of phytochemical-based strategies to reverse drug resistance by inhibiting these transporters. Compounds such as tetrandrine and resveratrol have shown promise in sensitizing drug-resistant cancer cells. Understanding the complex interplay between BCRP regulation and these signaling pathways is essential for the development of effective therapeutic strategies to counteract cancer. Targeting multiple pathways or employing combination therapies may offer new avenues to overcome MDR and improve treatment outcomes for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioprospecting Laboratory, Department of Botany, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.
- Bioprospecting Laboratory, Department of Botany, Bharathiar University, Coimbatore 641046, Tamil Nadu, India. Electronic address: drparimel@gmail.com.
Förderung
- Bharathiar University
- University Grants Commission Department of Atomic Energy Consortium for Scientific Research
- University Grants Commission
- Department of Botany, University of Calcutta
- Tamil Nadu State Council for Higher Education
Zitieren
APA
Anish Ruban, S., Raj, F. J., & Thangaraj, P. (2025). Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189349
Vancouver
Anish Ruban S, Raj FJ, Thangaraj P. Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189349
BibTeX
@article{AnishRuban2025,
author = {Anish Ruban, S and Raj, Francis Jegan and Thangaraj, Parimelazhagan},
title = {Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189349}
}
EUVIMED